Treating major depression and comorbid disorders with transcranial magnetic stimulation
- 15 July 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Affective Disorders
- Vol. 276, 453-460
- https://doi.org/10.1016/j.jad.2020.07.025
Abstract
No abstract availableFunding Information
- National Center for Research Resources
This publication has 42 references indexed in Scilit:
- Executive FunctionsAnnual Review of Psychology, 2013
- Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: A meta-analysis and review.Psychological Bulletin, 2013
- Treatment-resistant depression: therapeutic trends, challenges, and future directionsPatient Preference and Adherence, 2012
- Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized TrialsAmerican Journal of Psychiatry, 2009
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLoS Medicine, 2009
- Placebo Response of Non-Pharmacological and Pharmacological Trials in Major Depression: A Systematic Review and Meta-AnalysisPLOS ONE, 2009
- Quetiapine augmentation of treatment-resistant depression: a comparison with lithiumCurrent Medical Research and Opinion, 2007
- What Role Do Atypical Antipsychotic Drugs Have in Treatment-Resistant Depression?British Journal of Psychology, 2002
- Double-Blind, Placebo-Controlled Trial of the Use of Lithium to Augment Antidepressant Medication in Continuation Treatment of Unipolar Major DepressionAmerican Journal of Psychiatry, 2000
- The Unity and Diversity of Executive Functions and Their Contributions to Complex “Frontal Lobe” Tasks: A Latent Variable AnalysisCognitive Psychology, 2000